Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Lab-grown skin layer could replace animal testing
Scientists have developed the first ever lab grown epidermis.
Skin model could help develop treatments for skin conditions

Scientists have developed the first ever lab-grown skin layer. It could replace animal testing for drugs and cosmetics, as well as helping to develop new treatments for skin disorders.

The skin layer has been grown from human stem cells. It is the first lab-grown epidermis with the functional permeability barrier needed for drug testing.

Leading the research team from Kings College London, Dr Dusko Ilic said their new method could be scaled up for commercial testing of drugs and cosmetics.

Scientists used human stem cells to create an unlimited supply of pure keratinocytes - the main cell type in the epidermis.

These were used to produce 3D epidermal equivalents in a high-to-low humidity environment to build the functional barrier for protecting the body from losing moisture and preventing entry of chemicals, toxins and microbes.

The study, which has been published in the journal Stem Cell Reports, was carried out in collaboration with the San Francisco Veteran Affairs Medical Center (SFVAMC).

Scientists say the model can be used to study conditions such as ichthyosis (dry, flaky skin) and atopic dermatitis, where the skin's barrier is defective.

Dr Theodora Mauro, leader of the SFVAMC team says: "We can use the model to study how the skin barrier develops normally, how the barrier is impaired in different diseases and how we can stimulate its repair and recovery."

Furthermore, Dr Ilic says the model could be tailored to study particular skin conditions and sensitivities in different populations, by growing epidermal equivalents representing different types of skin.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.